|
|
EXCLUSIVE: Small Biotech Hoth Therapeutics Claims Experimental Obesity Drug Topped Famed Wegovy In Preclinical Study
|
|
|
|
FDA Uncertainty Pushes Analyst To Lower Hims & Hers Forecast
|
|
|
|
Hims & Hers Under Fire, Stock Tanks on Federal Crackdown, Patent War
|
|
|
|
China Warning Hampers Budding Stock Market Rally But Helps Gold; Pay Attention To Historic Takaichi Win
|
|
|
|
Super Bowl Commercials 2026: Complete List Of Ads, The Companies Behind Them And Who Won Over Fans
|
|
|
|
'Novo's Obesity Pill TV Ad Includes Misleading Claims, FDA Says'- Bloomberg
|
|
|
|
Novo Nordisk Takes Legal Action Against Hims & Hers Over Wegovy Knock Offs
|
|
|
|
Novo Nordisk shares are trading higher after the company announced it filed a lawsuit against Novo Nordisk for patent infringement. The company began a 15 billion share repurchase.
|
|
|
|
Novo Nordisk Begins DKK 15B Share Repurchase, First Tranche At DKK 3.8B In Period From 4 February To 4 May 2026
|
|
|
|
Market-Moving News for February 9th
|
|